{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:38:37Z","timestamp":1762076317413,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024078","name":"Kyowa Kirin Farmac\u00e9utica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ad.2023.11.017","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T18:28:56Z","timestamp":1701541736000},"page":"T119-T129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage"],"prefix":"10.1016","volume":"115","author":[{"given":"B.","family":"Navarro Matilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.L.","family":"Ortiz Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Pujol Vallverd\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Combalia Escudero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Zapata Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gonz\u00e1lez Barca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Muniesa Montserrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Morillo And\u00fajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"P\u00e9rez Ferriols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rom\u00e1n Curto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fern\u00e1ndez de Misa Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hospital Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mar\u00edn Niebla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Rios Rull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"de la Cruz Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Izu Belloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mart\u00edn Garc\u00eda-Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Parera Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"C\u00f3rdoba Mascu\u00f1ano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Ram\u00f3n Quiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saus Carreres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"del Campo Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Machan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Viguera Ester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Blanco Garnelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.11.017_bib0155","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/10428194.2012.729831","article-title":"Incidence and survival patterns of cutaneous T-cell lymphomas in the United States","volume":"54","author":"Imam","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.ad.2023.11.017_bib0160","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/cancers12102921","article-title":"Epidemiology of cutaneous T-cell lymphomas: A systematic review and meta-analysis of 16,953 patients","volume":"12","author":"Dobos","year":"2020","journal-title":"Cancers."},{"key":"10.1016\/j.ad.2023.11.017_bib0165","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.ad.2023.11.017_bib0170","first-page":"467","article-title":"Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: An update","volume":"144","author":"Parker","year":"2009","journal-title":"G Ital Dermatol Venereol."},{"key":"10.1016\/j.ad.2023.11.017_bib0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome \u2013 Update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ad.2023.11.017_bib0180","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: Validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer Staging Proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2023.11.017_bib0185","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2023.11.017_bib0190","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s12094-016-1607-9","article-title":"Cancer incidence in Spain, 2015","volume":"19","author":"Galceran","year":"2017","journal-title":"Clin Transl Oncol."},{"key":"10.1016\/j.ad.2023.11.017_bib0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annonc\/mdy133","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Willemze","year":"2018","journal-title":"Ann Oncol."},{"key":"10.1016\/j.ad.2023.11.017_bib0200","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ad.2018.03.006","article-title":"The first year of the AEVD Primary Cutaneous Lymphoma Registry","volume":"109","author":"Pe\u00f1ate","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2023.11.017_bib0205","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: A guide to critical evaluation","volume":"29","author":"Larg","year":"2011","journal-title":"PharmacoEconomics."},{"key":"10.1016\/j.ad.2023.11.017_bib0210","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.ad.2023.11.017_bib0215","unstructured":"Precios p\u00fablicos. Servicio Andaluz de Salud [accessed 28 Mar 2023]. Available from: https:\/\/www.sspa.juntadeandalucia.es\/servicioandaluzdesalud\/profesionales\/relacion-con-la-ciudadania\/precios-publicos"},{"key":"10.1016\/j.ad.2023.11.017_bib0220","unstructured":"Decreto 25\/2010, de 17 de junio, por el que se actualizan los precios p\u00fablicos por actos asistenciales y servicios sanitarios prestados por la Gerencia Regional de Salud de Castilla y Le\u00f3n. Portal de Salud de la Junta de Castilla y Le\u00f3n [accessed 28 Mar 2023]. Available from: https:\/\/www.saludcastillayleon.es\/institucion\/es\/resumen-bocyl-legislacion-sanitaria\/decreto-25-2010-17-junio-actualizan-precios-publicos-actos-"},{"key":"10.1016\/j.ad.2023.11.017_bib0225","unstructured":"Decreto del DOG n.o 96 de 2014\/5\/21 - Xunta de Galicia [accessed 28 Mar 2023]. Available from: https:\/\/www.xunta.gal\/dog\/Publicados\/2014\/20140521\/AnuncioC3K1-140514-0001_es.html"},{"key":"10.1016\/j.ad.2023.11.017_bib0230","unstructured":"FFIS \u2013 Inicio [accessed 28 Mar 2023]. Available from: https:\/\/www.ffis.es\/"},{"key":"10.1016\/j.ad.2023.11.017_bib0235","unstructured":"Cat\u00e1logo precios p\u00fablicos\u2013 Acuerdo de 12 de junio de 2014, del Consejo de Gobierno, por el que se actualiza el Cat\u00e1logo de Servicios y Actividades de Naturaleza Sanitaria susceptibles de ser retribuidos mediante precios p\u00fablicos en el \u00e1mbito de la Comunidad de Madrid - BOCM. Bolet\u00edn Oficial de la Comunidad de Madrid - Legislaci\u00f3n - VLEX 519076726 [accessed 28 Mar 2023]. Available from: https:\/\/vlex.es\/vid\/cata-logo-retribuidos-mbito-519076726"},{"key":"10.1016\/j.ad.2023.11.017_bib0240","unstructured":"\u00d3rdenes del Departamento de Sanidad 2015-2019. Portal de Arag\u00f3n [accessed 28 Mar 2023]. Available from: https:\/\/www.aragon.es\/-\/ordenes-2015-2019"},{"key":"10.1016\/j.ad.2023.11.017_bib0245","unstructured":"Ministerio de Sanidad - Profesionales de la Salud \u2013 Nomenclator [accessed 28 Mar 2023]. Available from: https:\/\/www.sanidad.gob.es\/profesionales\/nomenclator.do"},{"key":"10.1016\/j.ad.2023.11.017_bib0250","unstructured":"Prices, Coupons & Patient Assistance Programs. Drugs.com. [accessed 28 Mar 2023]. Available from: https:\/\/www.drugs.com\/price-guide\/"},{"key":"10.1016\/j.ad.2023.11.017_bib0255","unstructured":"Medicines. SPS - Specialist Pharmacy Service. Published December 20, 2021 [accessed 28 Mar 2023]. Available from: https:\/\/www.sps.nhs.uk\/medicines\/nirmatrelvir-ritonavir\/"},{"key":"10.1016\/j.ad.2023.11.017_bib0260","first-page":"91","article-title":"Cost of early-stage mycosis fungoides treatments in Spain","volume":"12","author":"Ortiz-Romero","year":"2020","journal-title":"Clin Outcomes Res CEOR."},{"key":"10.1016\/j.ad.2023.11.017_bib0265","unstructured":"Scott NW, Fayers P, Aaronson NK, Bottomley A, Graeff A, Groenvold M, et al. EORTC QLQ-C30 Reference Values Manual. Published online July 2008 [accessed 28 Mar 2023]. Available from: https:\/\/abdn.pure.elsevier.com\/en\/publications\/eortc-qlq-c30-reference-values-manual"},{"key":"10.1016\/j.ad.2023.11.017_bib0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4321\/S1135-57272015000100010","article-title":"Coste del tratamiento del c\u00e1ncer de mama por estadio cl\u00ednico en el Pa\u00eds Vasco","volume":"89","author":"Arrospide","year":"2015","journal-title":"Rev Esp Salud P\u00fablica."},{"key":"10.1016\/j.ad.2023.11.017_bib0275","series-title":"Evaluaci\u00f3n econ\u00f3mica de medicamentos y tecnolog\u00edas sanitarias: Principios, m\u00e9todos y aplicaciones en pol\u00edtica sanitaria","first-page":"9","article-title":"Fundamento e introducci\u00f3n a la evaluaci\u00f3n econ\u00f3mica de medicamentos y tecnolog\u00edas sanitarias","author":"Soto \u00c1lvarez","year":"2012"},{"key":"10.1016\/j.ad.2023.11.017_bib0280","unstructured":"El impacto econ\u00f3mico y social del c\u00e1ncer en Espa\u00f1a [accessed 28 Mar 2023]. Available from: https:\/\/www.oliverwyman.es\/es\/media-center\/2020\/feb\/el-impacto-economico-y-social-del-cancer-en-espana.html"},{"key":"10.1016\/j.ad.2023.11.017_bib0285","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2017.03.006","article-title":"Contribution of health care factors to the burden of skin disease in the United States","volume":"76","author":"Lim","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2023.11.017_bib0290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaad.2017.08.060","article-title":"A risk adjustment approach to estimating the burden of skin disease in the United States","volume":"78","author":"Lim","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2023.11.017_bib0295","first-page":"190","article-title":"Health-related quality of life and economic implications of cutaneous T-cell lymphoma","volume":"182","author":"Semenov","year":"2020","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.11.017_bib0300","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s12094-018-1972-7","article-title":"The burden of cancer in Spain","volume":"21","author":"Bad\u00eda","year":"2019","journal-title":"Clin Transl Oncol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023009596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023009596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:32:14Z","timestamp":1762075934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731023009596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0001731023009596"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.11.017","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.08.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}